Wen Lv

Dr. Wen Lv

Sir run run shaw hospital, zhejiang university

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2020 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
YYYang Yi
Yang Yi
YXYe Xiaobin
Ye Xiaobin
CHChen Hui
Chen Hui
ZYZhong Yufa
Zhong Yufa
ZQZhang Qiaowei
Zhang Qiaowei
WLWen Lv
Wen Lv

7 January 2020 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
LJLuya Jin
Luya Jin
WLWen Lv
Wen Lv
GHGuocan Han
Guocan Han
LNLinhui Ni
Linhui Ni
DSDi Sun
Di Sun
WLWen Lv
Wen Lv

18 November 2021 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
LNLinhui Ni
Linhui Ni
WLWen Lv
Wen Lv
DSDi Sun
Di Sun
YSYi Sun
Yi Sun
YSYu Sun
Yu Sun
WLWen Lv
Wen Lv
Given the limited power of neuropsychological tests, there is a need for a simple, reliable means, such as gait, to identify mild dementia and its subtypes. However, gait characteristics of patients with post-stroke dementia (PSD) and Alzheimer’s disease (AD) are unclear. We sought to describe their gait signatures and to explore gait parameters distinguishing PSD from post-stroke non-dementia (PSND) and patients with AD. We divided 3-month post-stroke patients into PSND and PSD groups based on the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and the activity of daily living (ADL). Thirty-one patients with AD and thirty-two healthy controls (HCs) were also recruited. Ten gait parameters in one single and two dual-task gait tests (counting-backward or naming-animals while walking) were compared among the groups, with adjustment for baseline demographic covariates and the MMSE score. The area under the receiver operating characteristic curve (AUC) was used to identify parameters discriminating PSD from individuals with PSND and AD. Patients with PSD and patients with AD showed impaired stride length, velocity, stride time, and cadence while patients with PSD had altered stance and swing phase proportions (all p ≤ 0.01, post hoc). Patients with AD had smaller toe-off (ToA) and heel-to-ground angles (HtA) (p ≤ 0.01) than HCs in dual-task gait tests. Individuals with PSD had a shorter stride length, slower velocity, and altered stance and swing phase percentages in all tests (p ≤ 0.01), but a higher coefficient of variation of stride length (CoVSL) and time (CoVST) only in the naming animals-task gait test (p ≤ 0.001) than individuals with PSND. ToA and HtA in the naming animals-task gait test were smaller in individuals with AD than those with PSD (p ≤ 0.01). Statistical significance persisted after adjusting for demographic covariates, but not for MMSE. The pace and the percentage of stance or swing phase in all tests, CoVST in the dual-task paradigm, and CoVSL only in the naming animals-task gait test (moderate accuracy, AUC > 0.700, p ≤ 0.01) could distinguish PSD from PSND. Furthermore, the ToA and HtA in the naming animals-task gait paradigm discriminated AD from PSD (moderate accuracy, AUC > 0.700, p ≤ 0.01). Thus, specific gait characteristics could allow early identification of PSD and may allow non-invasive discrimination between PSD and AD, or even other subtypes of dementia.

29 July 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JCJiaye Cai
Jiaye Cai
MXMengru Xu
Mengru Xu
WLWen Lv
Wen Lv
YJYun Jiang
Yun Jiang
XZXu Zheng
Xu Zheng
YSYi Sun
Yi Sun
Accumulating efforts have been made to investigate cognitive impairment in stroke patients, but little has been focused on mild stroke. Research on the impact of mild stroke and different lesion locations on cognitive impairment is still limited. To investigate the underlying mechanisms of cognitive dysfunction in mild stroke at different lesion locations, electroencephalograms (EEGs) were recorded in three groups (40 patients with cortical stroke (CS), 40 patients with subcortical stroke (SS), and 40 healthy controls (HC)) during a visual oddball task. Power envelope connectivity (PEC) was constructed based on EEG source signals, followed by graph theory analysis to quantitatively assess functional brain network properties. A classification framework was further applied to explore the feasibility of PEC in the identification of mild stroke. The results showed worse behavioral performance in the patient groups, and PECs with significant differences among three groups showed complex distribution patterns in frequency bands and the cortex. In the delta band, the global efficiency was significantly higher in HC than in CS (p = 0.011), while local efficiency was significantly increased in SS than in CS (p = 0.038). In the beta band, the small-worldness was significantly increased in HC compared to CS (p = 0.004). Moreover, the satisfactory classification results (76.25% in HC vs. CS, and 80.00% in HC vs. SS) validate the potential of PECs as a biomarker in the detection of mild stroke. Our findings offer some new quantitative insights into the complex mechanisms of cognitive impairment in mild stroke at different lesion locations, which may facilitate post-stroke cognitive rehabilitation.

13 April 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
XFXiaoxiao Fu
Xiaoxiao Fu
JWJing Wang
Jing Wang
WLWen Lv
Wen Lv
HJHong Jiang
Hong Jiang
SHShu Han
Shu Han
Alzheimer’s disease (AD) is a neurological disorder characterized by neuronal cell death, tau pathology, and excessive inflammatory responses. Several vascular risk factors contribute to damage of the blood–brain barrier (BBB), secondary leak-out of blood vessels, and infiltration of inflammatory cells, which aggravate the functional disability and pathological changes in AD. Growth factor angiopoietin-1 (Ang-1) can stabilize the endothelium and reduce endothelial permeability by binding to receptor tyrosine kinase 2 (Tie2). C16 peptide (KAFDITYVRLKF) selectively binds to integrin ανβ3 and competitively inhibits leukocyte transmigration into the central nervous system by interfering with leukocyte ligands. In the present study, 45 male Sprague-Dawley (SD) rats were randomly divided into three groups: vehicle group, C16 peptide + Ang1 (C + A) group, and sham control group. The vehicle and C + A groups were subjected to two-vessel occlusion (2-VO) with artery ligation followed by Aβ1-42 injection into the hippocampus. The sham control group underwent sham surgery and injection with an equal amount of phosphate-buffered saline (PBS) instead of Aβ1-42. The C + A group was administered 1 mL of drug containing 2 mg of C16 and 400 µg of Ang-1 daily for 2 weeks. The sham control and vehicle groups were administered 1 mL of PBS for 2 weeks. Our results showed that treatment with Ang-1 plus C16 improved functional disability and reduced neuronal death by inhibiting inflammatory cell infiltration, protecting vascular endothelial cells, and maintaining BBB permeability. The results suggest that these compounds may be potential therapeutic agents for AD and warrant further investigation.

2 September 2025 in Brain Imaging and Behavior
Verified
Journal Article
Open access
PDF file
GXGuojun Xu
Guojun Xu
BLBin Lin
Bin Lin
YJYun Jiang
Yun Jiang
JMJie Ming
Jie Ming
LNLinhui Ni
Linhui Ni
AGand Lulu Gao
and Lulu Gao
The structural and functional characteristics of hippocampal subfields have been extensively studied in dementia, with findings indicating stronger associations with cognitive performance than those observed in the whole hippocampus (HP). However, the impact of post-stroke dementia (PSD) on the structural and functional connectivity between hippocampal subfields and cortical regions remains unclear. The objective of this study is to examine alterations in the functional and structural connectivity between hippocampal subfields and cortical regions in PSD. We collected resting-state functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) data from 24 PSD patients, 36 post-stroke non-demented (PSND) patients, and 21 normal controls (NC). These data were used to estimate fractional amplitude of low-frequency fluctuations (fALFF), fractional anisotropy (FA), and diffusivity maps in the hippocampal subfields. Additionally, we constructed functional and structural connectivity matrices between hippocampal subfields and cortical regions for each participant, highlighting group-specific connectivity alterations. Statistical analyses were conducted using a linear mixed model to compare group differences and assess the relationship between MRI measures and clinical evaluations. Our results revealed distinct PSD-related changes in functional connectivity, particularly with the temporal-occipital cortex, within hippocampal subfields compared to the whole HP. Notably, different subfields contributed differently to connectivity changes within the entire HP. Furthermore, we identified positive correlations between diffusivity in the bilateral hippocampal tails and illness duration in PSND patients, which were not observed in PSD. These findings highlight the significant impact of PSD on hippocampal subfields, with subfield analysis offering new insights into the underlying mechanisms of PSD.